AI-Based Multimodal Clinical Foundation Models for Complex Care

Abstract

AI-based multimodal clinical foundation models represent a paradigm shift in the management of complex medical conditions, integrating diverse patient data streams to support nuanced clinical decision-making. This review synthesizes current evidence on the development, implementation, and clinical utility of these advanced artificial intelligence systems. Key areas explored include the epidemiology of complex care needs, mechanistic underpinnings of multimodal model architecture, risk factors for suboptimal outcomes, clinical features addressed by these models, diagnostic and therapeutic applications, recent technological advances, and prevailing guideline recommendations. The review aims to equip clinicians with a comprehensive understanding of how these models can enhance care delivery and patient safety in multifaceted clinical scenarios.

Introduction

The increasing complexity of patient care in modern medicine, characterized by multimorbidity, polypharmacy, and intricate diagnostic pathways, necessitates advanced decision support tools. Artificial intelligence (AI) has emerged as a transformative force, with multimodal clinical foundation models at the forefront. These models are designed to assimilate heterogeneous data ranging from structured electronic health records (EHRs) and laboratory results to imaging studies and unstructured clinical notes enabling comprehensive patient profiling and evidence-based recommendations. The integration of diverse data modalities facilitates a holistic view of patient status, improving risk stratification, diagnostic accuracy, and therapeutic precision.

Epidemiology / Disease Burden

Complex clinical care is particularly prevalent among aging populations, patients with multiple chronic diseases, and those requiring coordinated multidisciplinary interventions. Epidemiological data indicate that over 30% of hospitalized adults in developed countries present with at least two chronic comorbid conditions, significantly increasing the risk of adverse outcomes, prolonged hospitalizations, and healthcare resource utilization. The multifaceted nature of these cases often overwhelms traditional clinical workflows, contributing to diagnostic delays, medication errors, and care fragmentation. The burden of complex care is expected to rise with demographic shifts and the increasing prevalence of chronic diseases globally, underscoring the urgent need for intelligent, scalable solutions.

Pathophysiology

While foundation models do not address biological pathophysiology directly, their architecture is inspired by the need to mirror the interconnectedness observed in complex disease states. The models employ deep learning mechanisms, such as transformers and attention networks, to capture intricate relationships between clinical features, laboratory trends, imaging findings, and narrative documentation. By learning from vast datasets encompassing millions of patient encounters, these models can recognize subtle patterns indicative of disease progression, complications, or therapeutic response, paralleling the pathophysiological interplay between organ systems and disease processes encountered in complex care.

Risk Factors

Key risk factors for adverse clinical outcomes in complex care populations include advanced age, frailty, polypharmacy, cognitive impairment, and social determinants such as socioeconomic deprivation and limited health literacy. In the context of AI model deployment, additional risks arise from data heterogeneity, missingness, and potential biases in training datasets. Inadequate model validation or poor generalizability across care settings may result in suboptimal recommendations, reinforcing the need for rigorous development and continuous monitoring of clinical foundation models.

Clinical Features

Multimodal clinical foundation models are uniquely positioned to analyze and interpret a wide array of clinical features relevant to complex care. These include temporal trends in vital signs and laboratory values, polypharmacy profiles, comorbidity clusters, and nuanced symptoms documented in free-text notes. The models facilitate early recognition of clinical deterioration, prediction of complications such as sepsis or acute kidney injury, and identification of patients at risk for readmission or adverse drug events. Their ability to synthesize structured and unstructured data enhances diagnostic granularity and supports personalized care planning.

Diagnosis

Diagnostic workflows in complex care are often hindered by fragmented data and cognitive overload. AI-based multimodal models address these challenges by providing real-time decision support, flagging abnormal patterns, and suggesting differential diagnoses based on aggregated patient information. Studies have demonstrated that these models can outperform traditional rule-based systems and human clinicians in specific diagnostic tasks, particularly when integrating radiology, pathology, and genomic data. Their deployment has the potential to reduce diagnostic errors, minimize redundant testing, and accelerate appropriate interventions.

Treatment & Management

The therapeutic management of complex patients often involves dynamic adjustment of medications, multidisciplinary care coordination, and individualized risk mitigation strategies. Multimodal foundation models support these processes by forecasting clinical trajectories, recommending evidence-based interventions, and facilitating communication between care teams. For example, models may identify optimal medication regimens in patients with multiple comorbidities, suggest preventive measures to avert hospital readmissions, or prioritize high-risk patients for intensive monitoring. Integration with EHRs enables seamless workflow augmentation and real-time clinical impact.

Recent Advances / Emerging Therapies

Recent years have witnessed rapid advances in the development and clinical validation of multimodal AI models. Techniques such as federated learning, self-supervised pretraining, and explainable AI are enhancing model robustness, transparency, and privacy compliance. Notable examples include large language models capable of medical reasoning, multimodal transformers integrating imaging and text, and clinical event prediction systems validated in prospective trials. Emerging therapies leveraging these models focus on closed-loop decision support, proactive care escalation, and data-driven population health management. The ongoing integration of genomics, wearable sensor data, and patient-reported outcomes is expected to further expand the scope and precision of these systems.

Guideline Recommendations

Professional societies and regulatory bodies increasingly recognize the potential of AI-based clinical foundation models, while emphasizing the importance of ethical deployment, data stewardship, and clinician oversight. Guidelines recommend rigorous validation across diverse populations, transparent reporting of model performance, and continuous post-deployment monitoring to ensure equity and safety. Interdisciplinary collaboration between clinicians, data scientists, and informaticians is encouraged to align model development with clinical needs and workflow realities. Clinician education on AI literacy and model interpretability is essential for safe and effective integration into practice.

Conclusion

AI-based multimodal clinical foundation models are poised to revolutionize the care of patients with complex medical needs. By harnessing the power of integrated data analytics, these systems offer unprecedented opportunities to enhance diagnostic accuracy, optimize therapeutic strategies, and improve patient outcomes. Ongoing research, robust clinical validation, and multidisciplinary collaboration will be pivotal in realizing the full potential of these models while safeguarding patient safety and ethical standards. As the field evolves, clinicians must remain engaged in the development and evaluation of AI tools to ensure their alignment with best practices and the nuanced realities of complex care delivery.